DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
BHF Brighthouse Financial
- 47.000
- +1.030+2.24%
Trading Dec 19 11:42 ET
2.79BMarket Cap-2.33P/E (TTM)
47.155High46.280Low99.48KVolume46.280Open45.970Pre Close4.65MTurnover0.17%Turnover RatioLossP/E (Static)59.35MShares54.73052wk High0.50P/B2.76BFloat Cap40.00052wk Low--Dividend TTM58.70MShs Float67.550Historical High--Div YieldTTM1.90%Amplitude12.050Historical Low46.732Avg Price1Lot Size
Brighthouse Financial Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 75.74%1.96B | 663.79%1.33B | 0 | -40.42%3.95B | 1,116.42%1.36B | -9.26%1.12B | -95.35%174M | -27.46%1.3B | 84.94%6.63B | 70.22%-134M |
| Total premiums earned | -7.22%180M | -14.22%181M | 2.54%202M | 25.08%828M | 35.33%226M | 19.75%194M | 26.35%211M | 18.67%197M | -6.36%662M | -0.60%167M |
| -Net premiums written | ---- | ---- | ---- | 25.08%828M | ---- | ---- | ---- | ---- | -6.36%662M | ---- |
| Net investment income | 268.93%1.14B | 177.56%546M | -249.09%-741M | -82.06%589M | 155.34%487M | -20.97%309M | -124.14%-704M | -41.94%497M | 765.92%3.28B | 7.47%-880M |
| Net realized gain loss on investments | -13.21%-60M | -85.94%-119M | 56.25%-42M | -7.46%-245M | 54.29%-32M | -29.27%-53M | 1.54%-64M | -84.62%-96M | -286.44%-228M | -218.18%-70M |
| Fee revenue and other income | 5.40%703M | -1.37%721M | -16.88%581M | -4.63%2.78B | 4.93%681M | -7.23%667M | 0.55%731M | -14.55%699M | -15.07%2.91B | 82.82%649M |
| -Fees and commissions | 3.32%560M | -3.49%580M | -28.05%436M | -5.75%2.3B | -0.55%546M | -9.21%542M | -1.31%601M | -10.88%606M | -18.29%2.44B | 119.60%549M |
| -Other income expense | 14.40%143M | 8.46%141M | 55.91%145M | 1.05%483M | 35.00%135M | 2.46%125M | 10.17%130M | -32.61%93M | 6.22%478M | -4.76%100M |
| Total expenses | 236.81%1.78B | 219.95%1.32B | -68.51%614M | 185.77%5.42B | 1,557.47%2.54B | -26.70%527M | -73.79%411M | 1,006.98%1.95B | 20.43%1.9B | 93.59%-174M |
| Loss adjustment expense | 233.33%632M | 146.81%286M | -153.58%-472M | 161.17%1.17B | 213.28%1.37B | -5.33%-474M | -193.28%-611M | 197.46%881M | -37.68%-1.91B | 69.76%-1.21B |
| Policyholder interest | 30.52%556M | 12.61%509M | 18.96%502M | 36.40%1.83B | 30.92%525M | 5.19%426M | 59.15%452M | 70.16%422M | 5.44%1.34B | 47.43%401M |
| Policy acquisition expense | -3.23%150M | -4.46%150M | -3.21%151M | -1.43%620M | -1.94%152M | -2.52%155M | -0.63%157M | -0.64%156M | -1.26%629M | -75.00%155M |
| Fees and commission expense | -1.08%92M | -1.09%91M | 0.00%92M | -10.07%366M | -4.30%89M | -5.10%93M | -9.80%92M | -19.30%92M | -19.88%407M | -26.77%93M |
| Selling general and administration | 2.92%176M | -7.57%171M | 4.19%174M | 12.83%730M | 5.61%207M | 5.56%171M | 25.00%185M | 18.44%167M | -2.71%647M | 6.52%196M |
| -General and administrative expense | 2.92%176M | -7.57%171M | 4.19%174M | 12.83%730M | 5.61%207M | 5.56%171M | 25.00%185M | 18.44%167M | -2.71%647M | 6.52%196M |
| Non-operating net interest income (expenses) | 0.00%-38M | 0.00%-38M | 0.00%-38M | 0.00%-153M | 0.00%-39M | 0.00%-38M | 0.00%-38M | 0.00%-38M | 35.71%-153M | 66.38%-39M |
| -Interest expense-non operating | 0.00%38M | 0.00%38M | 0.00%38M | 0.00%153M | 0.00%39M | 0.00%38M | 0.00%38M | 0.00%38M | -6.13%153M | -4.88%39M |
| Income from associates and other participating interests | 3.77%55M | 10.11%98M | 669.23%74M | -31.28%167M | 442.86%38M | 148.18%53M | -26.45%89M | -105.78%-13M | -82.53%243M | -97.67%7M |
| Income before tax | -68.14%188M | 105.91%14M | 5.97%-614M | -131.15%-1.47B | -3,035.00%-1.17B | 15.23%590M | -110.89%-237M | -132.60%-653M | 135.54%4.73B | -98.23%40M |
| Income tax | -90.83%10M | 67.74%-20M | 21.15%-123M | -143.28%-367M | -165.98%-258M | 12.37%109M | -114.35%-62M | -137.50%-156M | 134.90%848M | -121.51%-97M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -62.99%178M | 119.43%34M | 1.21%-491M | -128.50%-1.11B | -768.61%-916M | 15.90%481M | -110.03%-175M | -131.32%-497M | 135.68%3.88B | -92.45%137M |
| Net Income continuous operations | -62.99%178M | 119.43%34M | 1.21%-491M | -128.50%-1.11B | -768.61%-916M | 15.90%481M | -110.03%-175M | -131.32%-497M | 135.68%3.88B | -92.45%137M |
| Minority interest income | 0.00%2M | 0 | 0.00%2M | 0.00%5M | 0.00%1M | 0.00%2M | 0 | 0.00%2M | 0.00%5M | 0.00%1M |
| Net income attributable to the parent company | -63.26%176M | 119.43%34M | 1.20%-493M | -128.67%-1.11B | -774.26%-917M | 15.98%479M | -110.03%-175M | -131.48%-499M | 136.09%3.88B | -92.50%136M |
| Preferred stock dividends | 0.00%26M | 0.00%25M | 0.00%26M | -1.92%102M | -3.85%25M | 4.00%26M | -3.85%25M | -3.70%26M | 16.85%104M | 23.81%26M |
| Other preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -66.89%150M | 104.50%9M | 1.14%-519M | -132.16%-1.21B | -956.36%-942M | 16.75%453M | -111.63%-200M | -133.70%-525M | 142.92%3.78B | -93.87%110M |
| Basic earnings per share | -64.02%2.49 | 103.99%0.12 | -6.48%-8.22 | -135.55%-18.39 | -1,020.75%-14.8339 | 27.68%6.92 | -113.06%-3.01 | -138.09%-7.72 | 179.02%51.73 | 198.70%1.6111 |
| Diluted earnings per share | -64.15%2.47 | 103.99%0.12 | -6.48%-8.22 | -135.85%-18.39 | -1,032.95%-14.8339 | 27.83%6.89 | -113.14%-3.01 | -138.39%-7.72 | 178.96%51.3 | 211.76%1.59 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |